Insider Activity of Karydas Daphne
According to the SEC Form 4 filings, Karydas Daphne, being in a position of
- director at Mineralys Therapeutics, Inc.,оver the last 12 months, has bought 0 shares, and sold 15000 shares for $689,797,over all time since 2025-11-13, has bought 0 shares, and sold 15000 shares for $689,797.
Biography of Karydas Daphne
No biography is available at this moment.